Can someone help to shed some light on JD Health(6618.hk) please? It debut last Dec 2020 with soaring stock prices but now it is trading below its debut price. What are the macro factors affecting the stock and is anyone long on it?
Wouldn’t healthcare be one of the resilient industry? Furthermore the potential for scale in PRC seemsbig to tap into. Thank you for anyone’s shedding some light! [Bless] [Bless] [Bless]
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- 白丁一个·2021-08-19我也被套，今天还是加仓了。虽然只是个主营卖套套的，但也算是个医疗入口。现阶段是杀估值。谈基本面都没有意义，你看腾讯都跌成这样。前期资本炒作太厉害了，现在退潮了。我打算等财报出了再决定要不要割肉。不要和趋势作对。最后说一句健康医疗行业肯定是向上的，国家是支持那些为大众服务的行业，不垄断赚的少了，就看市场增速能不能弥补了。1Report